Africa Malaria Treatment Market – Industry Trends and Forecast to 2031

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Pharmaceutical Africa Malaria Treatment Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

Africa Malaria Treatment Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Jan 2024
  • Country Level
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

Africa Malaria Treatment Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
 2024 –2031
Diagram 시장 규모(기준 연도)
 USD 51.35 million
Diagram 시장 규모(예측 연도)
 USD 64.78 million
Diagram 연평균 성장률
 %
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
잠금 해제 요청

>아프리카 말라리아 치료 시장, 대리인별(Plasmodium Falciparum, P.Vivax, P.Ovale, P.Malariae, P.Knowlelsi), 유형별(약물, 예방접종, 기타), 치료 유형(억제 치료, 근본적 치료), 약물 유형(제네릭, 브랜드), 투여 경로(경구, 비경구), 최종 사용자(병원, 전문 병원, 가정 의료, 기타), 유통 채널(직접 입찰, 병원 약국, 소매 약국, 온라인 약국, 기타) - 업계 동향 및 2031년까지의 예측.

아프리카 말라리아 치료 시장 분석 및 규모

말라리아는 감염된 암컷 아노펠레스 모기의 물림을 통해 퍼지는 감염성 질환으로, 기생충을 인체로 옮깁니다. 또한, 이 기생충은 간세포에 침투하여 증식하고 자랍니다. 아프리카 말라리아 치료 시장을 주도하는 주요 요인은 정부의 인식 이니셔티브 증가와 새로운 항말라리아 약물에 대한 연구 급증입니다. 그러나 개발도상국의 의료에 대한 인식 부족은 시장 성장을 제한하는 주요 요인입니다. 하이드록시 클로로퀸 과 클로로퀸의 생산, 수입 및 수출 증가는 시장에 기회가 될 것으로 예상됩니다. 항말라리아 약물과 관련된 부작용 및 위험은 시장에 도전이 될 것으로 예상됩니다.                                

Data Bridge Market Research는 2023년에 5,135만 달러였던 아프리카 말라리아 치료 시장이 2031년까지 6,478만 달러에 도달할 가능성이 높으며 예측 기간 동안 6.4%의 CAGR을 기록할 것으로 분석했습니다. 백신 접종 프로그램과 캠페인에 대한 관심이 높아지면서 "예방 접종"이 말라리아 치료 시장의 유형 세그먼트를 지배하고 있습니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

보고서 메트릭

세부

예측 기간

2024년부터 2031년까지

기준 연도

2023

역사적 연도

2022 (2016-2021년까지 사용자 정의 가능)

양적 단위

매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨

다루는 세그먼트

에이전트(Plasmodium Falciparum, P.Vivax, P.Ovale, P.Malariae, P.Knowlelsi), 유형(약물, 예방접종, 기타), 치료 유형(억제 치료, 근본적 치료), 약물 유형(제네릭, 브랜드), 투여 경로(경구, 비경구), 최종 사용자(병원, 전문 병원, 가정 의료, 기타), 유통 채널(직접 입찰, 병원 약국, 소매 약국, 온라인 약국, 기타)

적용 국가

나이지리아, 콩고 민주 공화국, 우간다, 니제르, 코트디부아르, 케냐, 남아프리카, 이집트, 기타 아프리카

시장 참여자 포함

Hikma Pharmaceuticals PLC(영국), Sun Pharmaceutical Industries Ltd.(인도), Zydus Cadila(인도), Cipla Inc.(인도), GlaxoSmithKline plc. (영국), Bliss GVS Pharma Ltd.(인도), MMV(스위스), Novartis AG(아위스), Taj Pharmaceuticals Limited(인도), Lupine Pharmaceuticals, Inc.(Lupine Limited의 자회사)(인도), AJANTA PHARMA( 인도), Strides Pharma Science Limited(인도), sanofi-aventis US LLC(Sanofi 자회사)(프랑스), Viatris Inc.(미국)

시장 기회
  • 약물 개발의 혁신
  • 공공-민간 파트너십 확대

시장 정의

말라리아 치료에는 모기 물림을 통해 전파되는 플라스모디움 종에 의한 기생충 감염을 퇴치하기 위한 다각적인 접근 방식이 포함됩니다. 주요 목표는 혈류에서 기생충을 제거하고 합병증을 예방하는 것입니다. 일반적으로 항말라리아 약물은 기생충 종과 감염의 심각성에 따라 사용됩니다. 아르테미시닌 기반 복합 요법(ACT)은 기생충의 수명 주기를 표적으로 삼는 효능으로 인해 종종 최전선 약물입니다. 클로로퀸, 키닌 또는 아토바퀴논-프로구아닐과 같은 다른 약물은 약물 내성 패턴에 따라 사용될 수 있습니다.             

아프리카 말라리아 치료 시장 동향

운전자

  • 기술의 발전이 증가하다

개선된 진단 도구와 혁신적인 치료 접근 방식과 같은 기술의 발전은 말라리아 치료의 진전을 촉진합니다. 신속한 진단 검사(RDT), 진료소 기기, 모바일 건강 솔루션에 대한 접근성은 말라리아의 진단 및 관리에 혁명을 일으킬 수 있습니다.

  • 개선된 의료 인프라

특히 서비스가 부족한 농촌 지역에서 의료 인프라를 강화하면 양질의 의료 서비스에 대한 접근성을 높일 수 있는 기회가 제공됩니다. 진료소를 짓고, 의료 종사자를 교육하고, 필수 의료 용품을 확보하는 것은 말라리아 치료 결과에 상당한 영향을 미칠 수 있습니다.

기회

  • 약물 개발의 혁신

제약 회사와 연구자들이 새롭고 더 효과적인 항말라리아 약물을 개발할 기회가 있습니다. 연구 개발에 투자하면 약물 내성 균주에 맞서 싸우고 부작용이 적은 새로운 화합물을 발견하여 말라리아 치료에 혁명을 일으킬 수 있습니다.

  • 공공-민간 파트너십 확대

정부, 비정부 기구, 자선 재단, 민간 기업 간의 협력은 자원과 전문성을 모을 수 있는 기회를 제공합니다. 공공-민간 파트너십은 연구, 인프라 개발, 약물 및 모기 구제 조치 배포를 위한 자금 조달을 용이하게 할 수 있습니다.

제약

  • 규제 승인 및 준수

Regulatory bodies in African countries are responsible for approving and registering medications, ensuring they meet safety and efficacy standards. However, varying regulatory frameworks across different countries can create hurdles for pharmaceutical companies aiming to introduce new drugs to multiple markets simultaneously. Delays in approvals impact the availability of potentially beneficial medications.

  • Drug resistance

The emergence of drug-resistant strains of the malaria parasite has been a significant hurdle. Resistance to commonly used antimalarial drugs like chloroquine and sulfadoxine-pyrimethamine has complicated treatment and necessitated the adoption of more expensive and complex therapies.

Challenge

  • Diagnostic limitations

Accurate and timely diagnosis of malaria is crucial for effective treatment. However, access to reliable diagnostic tools, particularly in remote areas, is a challenge. Rapid diagnostic tests (RDTs) are not always readily available or affordable, leading to misdiagnosis or delayed treatment.

This malaria treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the malaria treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In February 2018, Cipla Ltd. received confirmation of approval from the World Health Organization (WHO) Prequalification Programme for their 100mg rectal artesunate suppositories (RAS). It is for the pre-referral management of severe malaria. It has enhanced the market growth of the company
  • In July 2018, Lupin Pharmaceuticals, Inc. announced that its hydroxychloroquine sulfate tablets got approval from USFDA. The approval has accelerated the company's growth trajectory, particularly in the long term, which is anticipated to strengthen its position in the market

Africa Malaria Treatment Market Scope

The Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.

Agent

  • Plasmodium Falciparum
  • P. Vivax
  • P. Ovale
  • P. Malariae
  • P. Knowlelsi.

Type                                                                     

  • Medication
  • Vaccination
  • Others

Treatment

  • Suppressive treatment
  • Radical treatment

Drug Type

  • Branded
  • Generics

Route of Administration

  • Oral
  • Parenteral

End User

  • Hospitals
  • Specialty clinics
  • Home healthcare
  • Others

Distribution Channel

  • Direct tender
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Others

Malaria Treatment Market Country Analysis/Insights

The Africa malaria treatment market is segmented into seven notable segments based on agent, type, treatment, drug type, route of administration, end user and distribution channel.

The countries covered in the market report are Nigeria, Democratic Republic of Congo, Uganda, Coste D’ Ivoire, Niger, Kenya, Egypt, South Africa, and the rest of Africa.

Nigeria is expected to dominate and grow with the most promising growth due to the rapidly increasing patients and advancements in technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.   

Competitive Landscape and Africa Malaria Treatment Market Share Analysis

The Africa malaria treatment market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Africa malaria treatment market.

Some of the major players operating in the Africa malaria treatment market are:

  • Hikma Pharmaceuticals PLC (U.K.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Zydus Cadila (India)
  • Cipla Inc. (India)
  • GlaxoSmithKline plc. (U.K.)
  • Bliss GVS Pharma Ltd. (India)
  • MMV (Switzerland)
  • Novartis AG (Awitzerland)
  • Taj Pharmaceuticals Limited (India)
  • Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited) (India)
  • AJANTA PHARMA (India)
  • Strides Pharma Science Limited (India)
  • sanofi-aventis U.S. LLC (A Subsidiary of Sanofi) (France)
  • Viatris Inc. (U.S.)

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of AFRICA MALARIA TREATMENT MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market end user coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. AFRICA MALARIA TREATMENT MARKET: REGULATIONS
  6. Summary write-up (Africa)
  7. Pipeline analysis
  8. Market Overview
    1. Drivers
      1. High prevalence and disease burden of malaria in Africa
      2. Rise in medical insurance
      3. Humid climatic conditions and rising number of mosquitoES (Anopheles gambiae complex) in certain parts of Africa
    2. Restraints
      1. Adverse effects and risks associated with antimalariaL drugs
      2. Lack of awareness related to symptoms of malaria
      3. Low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment
    3. OpportunitIES
      1. strategic initiatives by major players
      2. increasing launch of new products
      3. Increase in production and export as well as import of hydroxychloroquine and chloroquine
    4. Challenges
      1. Regulatory challenges to antimalarial drug approval
      2. Achieving universal access
  9. COVID-19 IMPACT ON THE AFRICA MALARIA TREATMENT MARKET
    1. PRICE IMPACT
    2. IMPACT ON SUPPLY CHAIN
    3. IMPACT ON DEMAND
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. africa malaria treatment MARKET, By agent
    1. overview
    2. Plasmodium Falciparum
    3. P. Vivax
    4. P. Ovale
    5. P. Malariae
    6. P. Knowlelsi
  11. AFRICA MALARIA TREATMENT MARKET, By type
    1. overview
    2. medication
      1. Chloroquine
      2. Primaquine
      3. Artemisinin-Based Combination Therapy (ACT)
        1. ARTEMETHER–LUMEFANTRINE
        2. ARTESUNATE-AMODIAQUINE
        3. DIHYDROARTEMISININ-PIPERAQUINE
        4. OTHERS
      4. Quinine
      5. Hydroxychloroquine
      6. Mefloquine
      7. Non-Artemisinin Based Combinations (Non-ACTs)
        1. SULFADOXINE-PYRIMETHAMINE WITH CHLOROQUINE
        2. SULFADOXINE-PYRIMETHAMINE WITH AMODIAQUINE
        3. OTHERS
      8. Others
    3. vaccination
      1. Rts,S/As01
      2. Pfspz
      3. Others
  12. AFRICA MALARIA TREATMENT MARKET, By treatment type
    1. overview
    2. Suppressive Treatment
    3. Radical Treatment
  13. AFRICA MALARIA TREATMENT MARKET, By Drug Type
    1. overview
    2. generics
    3. branded
      1. Artefan
      2. Coartem
      3. Riamet
      4. Malarone
      5. Eurartesim
      6. Lonart
      7. Others
  14. AFRICA MALARIA TREATMENT MARKET, By route of administration
    1. overview
    2. oral
    3. Parenteral
      1. Intravenous
      2. Intramuscular
      3. Subcutaneous
  15. AFRICA MALARIA TREATMENT MARKET, By end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. Home Healthcare
    5. others
  16. AFRICA MALARIA TREATMENT MARKET, By distribution channel
    1. overview
    2. direct tender
    3. Hospital Pharmacies
    4. Retail Pharmacies
    5. Online Pharmacies
    6. Others
  17. Africa malaria treatment market, BY Country
    1. NIGERIA
    2. DEMOCRATIC REPUBLIC OF THE CONGO
    3. UGANDA
    4. NIGER
    5. CÔTE D’IVOIRE
    6. KENYA
    7. SOUTH AFRICA
    8. EGYPT
    9. REST OF AFRICA
  18. Africa MALARIA TREATMENT Market: COMPANY landscape
    1. company share analysis: Africa
  19. swot analysis
  20. company profile
    1. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. cipla inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. company share analysis
      4. product portfolio
      5. RECENT DEVELOPMENTS
    3. Strides Pharma Science Limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. Hikma Pharmaceuticals PLC
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. Recent development
    5. Sun Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    6. AJANTA PHARMA.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    7. Bliss GVS Pharma Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    8. GlaxoSmithKline plc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    9. Lupin Pharmaceuticals, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    10. MMV
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. sanofi-aventis U.S. LLC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    12. Taj Pharmaceuticals Limited
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    14. Zydus Cadila
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. Recent development
  21. questionnaire
  22. related reports

표 목록

TABLE 1 Africa malaria treatment Market, pipeline analysis

TABLE 2 ESTIMATED Malaria Cases and Deaths, by Region, 2018

TABLE 3 Regulatory Challenges to Antimalarial Drug Approval.

TABLE 4 Challenges and problems that drive the R&D framework

TABLE 5 AFRICA MALARIA TREATMENT MARKET, By Agent, 2019-2028 (USD thousand)

TABLE 6 Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 7 Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 8 Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 9 Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 10 Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 11 Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 12 Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 13 Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 14 Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 15 Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 16 Africa Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)

TABLE 17 Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 18 Africa Malaria treatment Market, By country, 2019-2028 (USD Thousand)

TABLE 19 Nigeria Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 20 Nigeria Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 21 Nigeria Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 22 Nigeria Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 23 Nigeria Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 24 Nigeria Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 25 Nigeria Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 26 Nigeria Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 27 Nigeria Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 28 Nigeria Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 29 Nigeria Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 30 Nigeria Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 31 Nigeria Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 32 Democratic Republic of the Congo Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 33 Democratic Republic of the Congo Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 34 Democratic Republic of the Congo Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 35 Democratic Republic of the Congo Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 36 Democratic Republic of the Congo Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 37 Democratic Republic of the Congo Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 38 Democratic Republic of the Congo Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 39 Democratic Republic of the Congo Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 40 Democratic Republic of the Congo Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 41 Democratic Republic of the Congo Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 42 Democratic Republic of the Congo Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 43 Democratic Republic of the Congo Malaria Treatment Market, By End User, 2019-2028 (USD Thousand)

TABLE 44 Democratic Republic of the Congo Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 45 Uganda Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 46 Uganda Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 47 Uganda Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 48 Uganda Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 49 Uganda Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 50 Uganda Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 51 Uganda Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 52 Uganda Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 53 Uganda Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 54 Uganda Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 55 Uganda Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 56 Uganda Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 57 Uganda Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 58 Niger Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 59 Niger Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 60 Niger Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 61 Niger Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 62 Niger Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 63 Niger Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 64 Niger Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 65 Niger Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 66 Niger Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 67 Niger Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 68 Niger Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 69 Niger Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 70 Niger Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 71 Côte d’Ivoire Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 72 Côte d’Ivoire Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 73 Côte d’Ivoire Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 74 Côte d’Ivoire Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 75 Côte d’Ivoire Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 76 Côte d’Ivoire Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 77 Côte d’Ivoire Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 78 Côte d’Ivoire Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 79 Côte d’Ivoire Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 80 Côte d’Ivoire Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 81 Côte d’Ivoire Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 82 Côte d’Ivoire Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 83 Côte d’Ivoire Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 84 Kenya Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 85 Kenya Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 86 Kenya Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 87 Kenya Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 88 Kenya Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 89 Kenya Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 90 Kenya Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 91 Kenya Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 92 Kenya Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 93 Kenya Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 94 Kenya Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 95 Kenya Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 96 Kenya Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 97 South Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 98 South Africa Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 99 South Africa Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 100 South Africa Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 101 South Africa Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 102 South Africa Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 103 South Africa Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 104 South Africa Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 105 South Africa Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 106 South Africa Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 107 South Africa Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 108 South Africa Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 109 South Africa Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 110 Egypt Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

TABLE 111 Egypt Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 112 Egypt Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 113 Egypt Artemisinin-Based Combination Therapy (ACT) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 114 Egypt Non-Artemisinin Based Combinations (Non-ACTs) Medication in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 115 Egypt Vaccination in Malaria Treatment Market, By Type, 2019-2028 (USD Thousand)

TABLE 116 Egypt Malaria Treatment Market, By Treatment Type, 2019-2028 (USD Thousand)

TABLE 117 Egypt Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 118 Egypt Branded in Malaria Treatment Market, By Drug Type, 2019-2028 (USD Thousand)

TABLE 119 Egypt Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 120 Egypt Parenteral in Malaria Treatment Market, By Route of Administration, 2019-2028 (USD Thousand)

TABLE 121 Egypt Malaria Treatment Market, By End User 2019-2028 (USD Thousand)

TABLE 122 Egypt Malaria Treatment Market, By Distribution Channel, 2019-2028 (USD Thousand)

TABLE 123 Rest of Africa Malaria Treatment Market, By Agent, 2019-2028 (USD Thousand)

그림 목록

FIGURE 1 Africa malaria treatment MARKET: segmentation

FIGURE 2 AFRICA MALARIA TREATMENT MARKET: data triangulation

FIGURE 3 AFRICA MALARIA TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 AFRICA MALARIA TREATMENT MARKET: REGIONAL vs COUNTRY MARKET ANALYSIS

FIGURE 5 AFRICA MALARIA TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 AFRICA MALARIA TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 AFRICA MALARIA TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 AFRICA MALARIA TREATMENT MARKET: MARKET end user COVERAGE GRID

FIGURE 9 AFRICA MALARIA TREATMENT MARKET: vendor share analysis

FIGURE 10 AFRICA MALARIA TREATMENT MARKET: SEGMENTATION

FIGURE 11 increasing prevalence of MALARIA, RISING MEDICAL HEALTHCARE INSURANCE, AND humid climatic conditions in africa are expected to drive THE AFRICA MALARIA TREATMENT MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 Plasmodium Falciparum segment is expected to account for the largest share of the AFRICA MALARIA TREATMENT MARKET in 2021 and 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AFRICA MALARIA TREATMENT MARKET

FIGURE 14 Malaria Cases in 10 highest-burden countries in Africa, 2010-2017

FIGURE 15 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2020

FIGURE 16 AFRICA MALARIA TREATMENT MARKET: By AGENT, 2019-2028 (USD thousand)

FIGURE 17 AFRICA MALARIA TREATMENT MARKET: By AGENT, CAGR (2021-2028)

FIGURE 18 AFRICA MALARIA TREATMENT MARKET: By AGENT, LIFELINE CURVE

FIGURE 19 AFRICA MALARIA TREATMENT MARKET: By type, 2020

FIGURE 20 AFRICA MALARIA TREATMENT MARKET: By type, 2019-2028 (USD thousand)

FIGURE 21 AFRICA MALARIA TREATMENT MARKET: By type, CAGR (2021-2028)

FIGURE 22 AFRICA MALARIA TREATMENT MARKET: By type, LIFELINE CURVE

FIGURE 23 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2020

FIGURE 24 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, 2019-2028 (USD thousand)

FIGURE 25 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, CAGR (2021-2028)

FIGURE 26 AFRICA MALARIA TREATMENT MARKET: TREATMENT TYPE, LIFELINE CURVE

FIGURE 27 AFRICA MALARIA TREATMENT MARKET: By drug type, 2020

FIGURE 28 AFRICA MALARIA TREATMENT MARKET: By drug type, 2019-2028 (USD thousand)

FIGURE 29 AFRICA MALARIA TREATMENT MARKET: By drug type, CAGR (2021-2028)

FIGURE 30 AFRICA MALARIA TREATMENT MARKET: By drug type, LIFELINE CURVE

FIGURE 31 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2020

FIGURE 32 AFRICA MALARIA TREATMENT MARKET: By route of administration, 2019-2028 (USD thousand)

FIGURE 33 AFRICA MALARIA TREATMENT MARKET: By route of administration, CAGR (2021-2028)

FIGURE 34 AFRICA MALARIA TREATMENT MARKET: By route of administration, LIFELINE CURVE

FIGURE 35 AFRICA MALARIA TREATMENT MARKET: By end user, 2020

FIGURE 36 AFRICA MALARIA TREATMENT MARKET: By end user, 2019-2028 (USD thousand)

FIGURE 37 AFRICA MALARIA TREATMENT MARKET: By end user, CAGR (2021-2028)

FIGURE 38 AFRICA MALARIA TREATMENT MARKET: By end user, LIFELINE CURVE

FIGURE 39 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2020

FIGURE 40 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, 2019-2028 (USD thousand)

FIGURE 41 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 42 AFRICA MALARIA TREATMENT MARKET: By DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 43 Africa Malaria treatment MARKET: SNAPSHOT (2020)

FIGURE 44 Africa Malaria treatment MARKET: BY COUNTRY (2020)

FIGURE 45 Africa Malaria treatment MARKET: BY COUNTRY (2021 & 2028)

FIGURE 46 Africa Malaria treatment MARKET: BY COUNTRY (2020 & 2028)

FIGURE 47 Africa Malaria treatment MARKET: BY Agent (2021-2028)

FIGURE 48 Africa MALARIA TREATMENT Market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Africa Malaria Treatment Market size will be worth USD 64.78 million by 2031 during the forecast period.
The Africa Malaria Treatment Market growth rate is 6.4% during the forecast period.
Improved healthcare infrastructure and Rising technological advancements are the growth drivers of the Africa Malaria Treatment Market.
The agent, type, treatment, drug type, route of administration, end user and distribution channel are the factors on which the Africa Malaria Treatment Market research is based.
The major companies in the Africa Malaria Treatment Market are Hikma Pharmaceuticals PLC (U.K.), Sun Pharmaceutical Industries Ltd. (India), Zydus Cadila (India), Cipla Inc. (India), GlaxoSmithKline plc. (U.K.), Bliss GVS Pharma Ltd. (India), MMV (Switzerland), Novartis AG (Awitzerland), Taj Pharmaceuticals Limited (India), Lupin Pharmaceuticals, Inc. (A Subsidiary of Lupin Limited) (India), AJANTA PHARMA (India), Strides Pharma Science Limited (India), sanofi-aventis U.S. LLC (A Subsidiary of Sanofi) (France), Viatris Inc. (U.S.).

관련 페이지 탐색

Banner